Are you Dr. Maenza?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 19 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
325 9th Ave
Seattle, WA 98104Phone+1 206-744-5100
Summary
- Dr. Janine Maenza, MD is an infectious disease specialist in Seattle, Washington. She is currently licensed to practice medicine in Washington and Maryland. She is affiliated with UW Medicine/Harborview Medical Center.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1993 - 1996
University of Virginia Medical CenterResidency, Internal Medicine, 1990 - 1993
University of Missouri-Columbia School of MedicineClass of 1990
Certifications & Licensure
WA State Medical License 1999 - 2026
MD State Medical License 1996 - 2001- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 9 citationsIntramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy AdultsSrilatha Edupuganti, Stephen C. De Rosa, Marnie Elizaga, Yiwen Lu, Xue Han
Vaccines. 2020-12-07 - 19 citationsA first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses.Kristen W Cohen, Stephen C De Rosa, William J Fulp, Allan C deCamp, Andrew Fiore-Gartland
Science Translational Medicine. 2023-05-24 - 107 citationsVaccination induces HIV broadly neutralizing antibody precursors in humans.David J Leggat, Kristen W Cohen, Jordan R Willis, William J Fulp, Allan C deCamp
Science. 2022-12-02
Grant Support
- Virological And Immunological Events In Acute/Early HIV-1 InfectionNational Center For Research Resources2005–2007
- Trial Of Nandrolone Decanoate In Women With HIV CachexiaNational Center For Research Resources2000–2002
- Chriron Quantiplex HIV 1 RNA 3 0 AssayNational Center For Research Resources1999–2002
- Effetcs Of Remune And Antiviral Therapy On HIV 1 Specific ImmunogenicityNational Center For Research Resources1998–2002
- ACTG 378: Effect Of Staggered Dosing On Pharmacokinetics Of Protease InhibitorNational Center For Research Resources1999
- ACTG 343--Protective Ransomized Double Blind Three Maintenance RegimensNational Center For Research Resources1998–1999
